272bio BV
272bio (BV) is a company in Gent, active in manufacture of pharmaceutical preparations, founded in 2021, with 5 employees (full-time equivalents). Financial year 2025: gross margin €104,252, profit -€631,558, equity -€225,308.
2 warnings: negative equity, three consecutive years of losses1 serious, 1 point of attentionShowHide
- Explained →
Negative equity. Equity was € -225,308 in financial year 2025. Debts exceed what the company owns; the board must in principle follow the alarm bell procedure.
Source: NBB, 2025 annual accounts - Explained →
Three consecutive years of losses. Loss in 2023, 2024, 2025 (€ -631,558 in 2025).
Source: NBB, annual accounts 2023 to 2025
Figures for 272bio, 2025NBB · abridged format
All figures, sector and health →Three ratios
How we calculateAnnual accounts 2025. The sector is recalculated every night.
See everything about 272bio
Health check, financial year in detail, 10 years of history and the board.
What happenedfrom the annual accounts and the CBE
- Annual accounts 2025 filed
- Annual accounts 2024 filed
- Annual accounts 2023 filed
- Incorporated as besloten vennootschap
Activities NACE-BEL 2025
21.201Manufacture of pharmaceutical preparationsMain activity
Establishments 1
- Suzanne Tassierstraat 1, 9052 Gent · since 28/01/20212.313.417.534
AuditProSanctions and politically exposed persons
Is a director on a sanctions list, or do they share the name of a politically exposed person? You can see it with Nummo Pro. Start your free trial
Publications in the Belgian Official Gazette 4 publications
- 09/10/2024BoardOntslagen, benoemingenDeed (pdf)
- 11/03/2024Incorporation and articlesRegistered officeStatuten (vertaling, coördinatie, overige wijzigingen, …), maatschappelijke zetelDeed (pdf)
- 08/07/2021Registered officeMaatschappelijke zetelDeed (pdf)
All 4 publications → list, timeline or per year
E-invoicing and VAT
Checking… · Peppol network and European VAT register (VIES)Read more
